Form 4 Filing Summary for Daniel J. Lippis

This Form 4 filing details a transaction by Daniel J. Lippis, CVP, TAVR at Edwards Lifesciences Corp. On July 7, 2026, Mr. Lippis disposed of 377 shares of Common Stock at a price of $95.18 per share. This transaction was related to satisfying tax withholding obligations incident to the vesting of securities. Following this transaction, Mr. Lippis beneficially owns 40,033.9103 shares of the company's common stock. The filing explicitly states that it reflects changes in beneficial ownership only and does not identify other securities of the Issuer beneficially owned by the Reporting Person.